FDA approves first generics of Novartis blockbuster MS drug

The U.S. FDA has approved three applications for first generics of Gilenya capsules for the treatment of relapsing forms of multiple sclerosis in adults.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news